Portsmouth Anaesthetic Group LLP

(Registration number: OC385820)
Balance Sheet as at 31 March 2026

The financial statements of Portsmouth Anaesthetic Group LLP (registered number OC385820) were approved by the Board and authorised for issue on 21 July 2026. They were signed on behalf of the limited liability partnership by:

......................................... S Bird Designated member

Portsmouth Anaesthetic Group LLP

Statement of Changes in Members’ Interests
At 31 March 2026

	Loans and other debts due to/(from) members
	Members' other amounts £	Total debt £	Total 2026 £
Members' interest at 1 April 2025	639,614	639,614	639,614
Members' remuneration charged as an expense	1,896,198	1,896,198	1,896,198
Members' interests after total comprehensive income	2,535,812	2,535,812	2,535,812
Drawings (including tax payments)	(1,641,792)	(1,641,792)	(1,641,792)
At 31 March 2026	894,020	894,020	894,020

	Loans and other debts due to/(from) members
	Members' other amounts £	Total debt £	Total 2025 £
Members' interest at 1 April 2024	531,652	531,652	531,652
Members' remuneration charged as an expense	1,513,903	1,513,903	1,513,903
Members' interests after total comprehensive income	2,045,555	2,045,555	2,045,555
Drawings (including tax payments)	(1,405,941)	(1,405,941)	(1,405,941)
At 31 March 2025	639,614	639,614	639,614

Portsmouth Anaesthetic Group LLP

Notes to the Financial Statements for the Year Ended 31 March 2026

1	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

General information and basis of accounting

The limited liability partnership is incorporated in England under the Limited Liability Partnership Act 2000. The address of the registered office is given on the limited liability partnership information page.

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The functional currency of Portsmouth Anaesthetic Group LLP is considered to be pounds sterling because that is the currency of the primary economic environment in which the limited liability partnership operates. Foreign operations are included in accordance with the policies set out below.

Revenue recognition

Revenue is recognised to the extent that the limited liability partnership obtains the right to consideration in exchange for its performance. Revenue is measured at the fair value of the consideration received, excluding discounts, rebates, VAT and other sales tax or duty.

Members' remuneration and division of profits

The SORP recognises that the basis of calculating profits for allocation may differ from the profits reflected through the financial statements prepared in compliance with recommended practice, given the established need to seek to focus profit allocation on ensuring equity between different generations and populations of members.

Consolidation of the results of certain subsidiary undertakings, the provision for annuities to current and former members, pension scheme charges, the spreading of acquisition integration costs and the treatment of long leasehold interests are all items which may generate differences between profits calculated for the purpose of allocation and those reported within the financial statements. Where such differences arise, they have been included within other amounts in the balance sheet.

Members' fixed shares of profits (excluding discretionary fixed share bonuses) and interest earned on members' balances are automatically allocated and, are treated as members' remuneration charged as an expense to the profit and loss account in arriving at profit available for discretionary division among members.
The remainder of profit shares, which have not been allocated until after the balance sheet date, are treated in these financial statements as unallocated at the balance sheet date and included within other reserves.

Tangible fixed assets

Individual fixed assets costing £150.00 or more are initially recorded at cost.

Portsmouth Anaesthetic Group LLP

Notes to the Financial Statements for the Year Ended 31 March 2026

Depreciation

Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated residual value, over their expected useful economic life as follows:

Asset class	Depreciation method and rate
Office equipment	30% - written down value

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the limited liability partnership will not be able to collect all amounts due according to the original terms of the receivables.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Members' interests

Amounts due to members after more than one year comprise provisions for annuities to current members and certain loans from members which are not repayable within twelve months of the balance sheet date.

2	Profit for the year before members' remuneration and profit shares

Arrived at after charging/(crediting)

	2026 £	2025 £
Depreciation	82	116

3	Particulars of employees

The average number of persons employed by the limited liability partnership during the year was 25 (2025 - 20).

Portsmouth Anaesthetic Group LLP

Notes to the Financial Statements for the Year Ended 31 March 2026

4	Tangible fixed assets

	Office equipment  £	Total £
Cost
At 1 April 2025	2,523	2,523
At 31 March 2026	2,523	2,523
Depreciation
At 1 April 2025	2,251	2,251
Charge for the year	82	82
At 31 March 2026	2,333	2,333
Net book value
At 31 March 2026	190	190
At 31 March 2025	272	272

5

Debtors

	2026 £	2025 £
Trade debtors	94,986	173,137
Prepayments and accrued income	2,460	-
Total current trade and other debtors	97,446	173,137

6	Creditors: Amounts falling due within one year

	2026 £	2025 £
Accruals and deferred income	7,750	7,500

7

Control

The members are the controlling party by virtue of their controlling interest in the limited liability partnership. The ultimate controlling party is the same as the controlling party.